| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.42 | 0.02 |